Back to Journals » Clinical Ophthalmology » Volume 3

Bevacizumab (Avastin®) for the management of anterior chamber neovascularization and neovascular glaucoma

Total article views   HTML views PDF downloads Totals
8,936 Dovepress* 8,936+ 3,261 12,197
Totals 8,936 3,261 12,197
*Since 20 November 2009
+Since July 2016

View citations on Google Scholar